
Senator · IL · D
Current term Jan 3, 2021 – Jan 3, 2027 · In the Senate since Jan 7, 1997
Official websiteContact formBiographical Directory
Portrait: U.S. Government Publishing Office, via unitedstates/images (public domain)
Lobbying reports (LD-2) whose issue descriptions explicitly cite a bill this member sponsored, cosponsored, or cast a recorded vote on. This documents an overlap in subject only. LD-2 reports generally do not name the members contacted, and a citation does not show contact with this member, influence, or the client's position on the bill. No matching record means none was found within coverage, not that no lobbying occurred.
Loading lobbying reportsCoverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026. Only the current version of each report is used.
39,466 report citations, newest first.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Pharmacy
$370,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…ngressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R. 1, the One Big Beautiful Bill; Comments to FDA on "Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Compounding Animal Drugs F…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Pharmacy
$370,000
Spent on own lobbying
CitesH.R. 1968· this member:Recorded votes on 6 roll calls
H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Gov…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Pharmacy
$370,000
Spent on own lobbying
CitesH.R. 7148· this member:Recorded votes on 8 roll calls
…Their Medication Act; H.R. 4409, the Fair Pharmacies for Federal Employees Act; S.3549/H.R.6837, the Fiduciary Accountability, Integrity and Reform (FAIR) Act; H.R.7148, the Consolidated Appropriations Act of 2026; Rural Health Transformation Program; Creation and Implementation of TrumpRx; Comments to FDA on RFI, "Re: Increas…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Pharmacy
$370,000
Spent on own lobbying
CitesS.Con.Res. 7· this member:Recorded votes on 27 roll calls
H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal year…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Defense
$370,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
TRICARE Pharmacy Network Oversight & Changes; H.R.8800/S.4784, the National Defense Authorization Act for Fiscal Year 2027; H.R. 6400/S.4106,the RxACCESS Act; Veterans Affairs Health Pharmacy Program;
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Budget/Appropriations
$370,000
Spent on own lobbying
CitesH.Con.Res. 14· this member:Recorded votes on 23 roll calls
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Budget/Appropriations
$370,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…ngressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.1, the One Big Beautiful Bill Act; H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R.7…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Budget/Appropriations
$370,000
Spent on own lobbying
CitesH.R. 1968· this member:Recorded votes on 6 roll calls
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Gov…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Budget/Appropriations
$370,000
Spent on own lobbying
CitesH.R. 7148· this member:Recorded votes on 8 roll calls
…H.R.1, the One Big Beautiful Bill Act; H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R.7148, the Consolidated Appropriations Act of 2026;
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · lobbying firm or registrant: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Budget/Appropriations
$370,000
Spent on own lobbying
CitesS.Con.Res. 7· this member:Recorded votes on 27 roll calls
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal year…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CVS HEALTH (AND SUBSIDIARIES) · lobbying firm or registrant: CVS HEALTH (AND SUBSIDIARIES)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Consumer Issues/Safety/Products
$2,040,000
Spent on own lobbying
CitesS. 1404· this member:Cosponsored
Issues related to organized retail crime. H.R. 2853/S. 1404, The Combating Organized Retail Crime Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CVS HEALTH (AND SUBSIDIARIES) · lobbying firm or registrant: CVS HEALTH (AND SUBSIDIARIES)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Advertising
$2,040,000
Spent on own lobbying
CitesS. 2068· this member:Cosponsored
S. 2068 - The End Prescription Drug Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL CATTLEMEN'S BEEF ASSOCIATION · lobbying firm or registrant: NATIONAL CATTLEMEN'S BEEF ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Budget/Appropriations
$40,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…tions provisions regarding USDA AMS regulation of the cattle industry including the Cattle Appropriations regarding New World Screwworm control and eradication HR 1 One Big Beautiful Bill Act implementation
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PETSMART LLC · lobbying firm or registrant: HARBINGER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$80,000
Paid to lobbying firm
CitesH.R. 1· this member:Recorded votes on 44 roll calls
Issues related to the implementation of H.R. 1.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE HOME DEPOT · lobbying firm or registrant: HARBINGER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Consumer Issues/Safety/Products
$70,000
Paid to lobbying firm
CitesS. 1404· this member:Cosponsored
H.R. 2853/S.1404 - Combatting Organized Retail Crime Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DIAGEO NORTH AMERICA, INC. · lobbying firm or registrant: HARBINGER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Agriculture
$50,000
Paid to lobbying firm
CitesH.R. 5371· this member:Recorded votes on 23 roll calls
…ing 2025-2030 Dietary Guidelines for America. Definition of industrial hemp and legalization contained in 2018 Farm Bill Reauthorization (Pub. L. No. 115-334). H.R. 5371, Continuing Appropriations including Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2026, provisions…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AIRLINES FOR AMERICA · lobbying firm or registrant: HARBINGER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Aviation/Airlines/Airports
$60,000
Paid to lobbying firm
CitesH.R. 5371· this member:Recorded votes on 23 roll calls
…nently disqualified from obtaining certain licenses issued by the Department of Homeland Security and the Department of Transportation, and for other purposes. H.R.5371 Continuing Appropriations and Extensions Act, 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AIRLINES FOR AMERICA · lobbying firm or registrant: HARBINGER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Aviation/Airlines/Airports
$60,000
Paid to lobbying firm
CitesS. 2806· this member:Recorded vote on 1 roll call
…A bill to provide for funding from the Airport and Airway Trust Fund for all Federal Aviation Administration activities in the event of a Government shutdown. S.2806 Eliminate Shutdowns Act S. 3031 / H.R.5851 A bill making continuing appropriations for essential Federal Aviation Administration and Transportation Security Ad…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SENIOR CARE PHARMACY COALITION · lobbying firm or registrant: SENIOR CARE PHARMACY COALITION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$320,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
…legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act. H.R. 8800 / S. 4784 National Defense Authorization Act for Fiscal Year 2027 (FY2027 NDAA). H.R. 3164 / S. 2426 Ensuring Community Access to Pharmacist Services Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SENIOR CARE PHARMACY COALITION · lobbying firm or registrant: SENIOR CARE PHARMACY COALITION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$320,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
…legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act. H.R. 8800 / S. 4784 National Defense Authorization Act for Fiscal Year 2027 (FY2027 NDAA). H.R. 3164 / S. 2426 Ensuring Community Access to Pharmacist Services Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INDEPENDENT SECTOR · lobbying firm or registrant: INDEPENDENT SECTOR
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$70,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
Protecting and strengthening the charitable tax deduction. The Charitable Act (S. 317/ H.R. 801). One Big, Beautiful Bill Act (H.R. 1). Volunteer Driver Tax Appreciation Act (S. 1177/H.R. 1582) Support for maintaining the Johnson Amendment protecting nonprofits from partisan politics Support…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CENOVUS US CORPORATION (FKA CENOVUS ENERGY) · lobbying firm or registrant: CENOVUS US CORPORATION (FKA CENOVUS ENERGY)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Clean Air and Water (quality)
$200,000
Spent on own lobbying
CitesS. 593· this member:Cosponsored
…ble Fuel Standard (RFS) issues relating to the Small Refinery Exemption program, RIN obligations, and Reid Vapor Pressure requirements, including H.R. 1346 and S. 593 Issues relating to EPA Refinery Risk Management Plan
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SANOFI US SERVICES INC · lobbying firm or registrant: SANOFI US SERVICES INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$1,250,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…Delinking; Drug Pricing - General issues; Drug Price Negotiations within Inflation Reduction Act; FDA Drug Development; FDA Issues - General; Issues related to HR 1 One Big Beautiful Bill; HR 830 HELP Copays Act; HR2880 Protecting Patients Against PBM Abuse Act; HR 5376 Inflation Reduction Act; HR 6423/S864 HELP Copays Act…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SANOFI US SERVICES INC · lobbying firm or registrant: SANOFI US SERVICES INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$1,250,000
Spent on own lobbying
CitesS. 4504· this member:Cosponsored
…e Immunization Rates; S. 1339 (118th): PBM Reform Act; S. 1375: HELP Copays Act; S. 1542 (118th) DRUG Act; S. 2027: Prescription Information Modernization Act; S.4504 / HR 8698 (118th): SCREEN for Type 1 Diabetes Act; Supply Chain; Tax Credits; Transplant; Vaccine Injury Compensation Program; Vaccines-General Issues.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SPACEX · lobbying firm or registrant: HARBINGER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Defense
$50,000
Paid to lobbying firm
CitesS. 4784· this member:Recorded vote on 1 roll call
The FY2027 National Defense Authorization Act (H.R.8800/S.4784): issues related to space launch competition.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing